APOA1 and Alzheimer disease: In the APP/PS1 transgenic mouse model of AD, a single intravenous injection of reconstituted HDL containing APOA-I and soy phosphatidylcholine was associated with reduced amyloid levels after one day, however, following four consecutive once-weekly injections, the improvement was no longer apparent [90].